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The biological effects of mainstream smoke (MS) from Indonesian-blended cigarettes with and without
added cloves, cloves extracted with hot ethanol, and extracted cloves replenished with eugenol or clove
oil were assessed in a 90-day inhalation study in rats. A separate 35-day inhalation study in rats was
performed with MS from American-blended cigarettes with 0%, 2.5%, 5% or 10% added eugenol. Effects
commonly seen in inhalation studies with MS were observed. These included histopathological changes
indicative of irritation in the entire respiratory tract and inﬂammatory responses in the lung. Adding
cloves to American- or Indonesian-blended cigarettes reduced the inﬂammatory response in the lung
but with no difference between the two blend types. When the clove oil was extracted (75% reduction
of eugenol achieved) from cloves, the inﬂammatory response in the lung was still reduced similarly to
whole cloves but the severity of histopathological changes in the upper respiratory tract was less
reduced. Add back of clove oil or pure eugenol reduced this response to a level similar to what was seen
with whole cloves. When eugenol was added to American-blended cigarettes, similar ﬁndings of reduced
lung inﬂammation and severity of histopathological changes in respiratory the tract was conﬁrmed.
These studies demonstrate a clear effect of cloves, and in particular eugenol, in explaining these ﬁndings.
 2014 Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/3.0/).1. Introduction
This publication is part of a series summarizing the in vitro and
in vivo toxicological assessment of kretek cigarettes. Smoke
composition and biological activity of mainstream smoke (MS)
from marketed and experimental kretek cigarettes were evaluated
on a comparative basis in smoke chemistry analyses, and in vitro
and in vivo toxicity studies. The studies were designed to cover
three main topics: (1) characterization of kreteks and comparison
relative to American-blended cigarettes, (2) impact of blend type
and cloves, and (3) impact of ingredients used in kretek cigarettes.
Further in depth information of this assessment is described in the
lead publication (Roemer et al., 2014c).
A comparison of the in vitro and in vivo effects of kretek
cigarettes with an American-blended cigarette revealed a lower
in vitro and in vivo toxicity of kretek cigarettes per mg of totalparticulate matter (TPM) (Piadé et al., 2014a,b). A series of
in vitro and in vivo experiments were designed to further
investigate these ﬁndings. In particular, the inﬂuence of (1) tobacco
blend, (2) cut cloves, (3) cloves extracted with hot ethanol to
remove oleoresin (clove essential oils), (4) add-back of oleoresin,
and (5) add-back of eugenol on the biological activity of
mainstream smoke (MS) in rats was determined. This approach
and the results from the in vivo studies are summarized in this
publication, whereas the smoke chemistry and in vitro results are
reported in Part 4 of this series (Roemer et al., 2014b).
2. Materials and methods
2.1. General
Detailed descriptions regarding the chemical analyses, toxico-
logical assays and statistical procedures can be found in the ﬁrst
of this series of publications (Roemer et al., 2014c).
The inhalation studies were conducted in an AAALAC-
accredited facility (Association for Assessment and Accreditation
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(Philip Morris Research Laboratories) where the care and use of
rats was conformed to the American Association for Laboratory
Animal Science Policy (www.aalas.org). The studies were approved
by the local Institutional Animal Care and Use Committee
according to Belgian legislation. They were conducted in
compliance with the OECD Principles on Good Laboratory Practice
(GLP) (as revised in 1997) and according to the OECD guideline
413, however, with shortened exposure period (OECD, 1981).
Details on the methodology have also been described elsewhere
(Vanscheeuwijck et al., 2002).2.2. Cigarettes
The experimental cigarettes with their main characteristics and
code names were as follows:
Set 1 cigarettes are American-blended cigarettes with the
addition of eugenol at 0%, 2.5%, 5%, or 10% and named US-0, US-2.5,
US-5, and US-10, respectively. The Gudang Garam International
Filter cigarette (thereafter referred to as Garam), a kretek cigarette
from the Indonesian market, was used as a comparator. In addition,
the standard reference cigarette 2R4F (Davis and Vaught, 1990)
was included.
Set 2 cigarettes were designed to investigate the impact of
whole cut cloves, essential oils of cloves, and clove matrix on the
in vivo toxicity of kretek cigarettes. The following cigarettes were
manufactured:
– IND: Indonesian-blended cigarette typical for kretek ciga-
rettes without any clove components.
– IND-C: Indonesian-blended cigarette representative of
kretek cigarettes with the addition of 370 mg untreated
cut cloves per cigarette, similar to the Kretek-R used in Part
2 and Part 3 (Piadé et al., 2014a,b), and the Control in Part 6
(Roemer et al., 2014a) and Part 7 (Schramke et al., 2014) of
this supplement.
– US-C: American-blended cigarettes with the addition of
370 mg untreated cut cloves per cigarette.
– IND-SC: Indonesian-blended cigarette representative of
kretek cigarettes with the addition of 370 mg of cloves that
had been depleted of oleoresins by hot ethanol extraction
(=spent clove).
– IND-SC-O: Indonesian-blended cigarette representative of
kretek cigarettes with the addition of 370 mg spent cloves
where the oleoresins have been added back. The eugenol
concentration measured in smoke and in ﬁller is approxi-
mately 90% of what is observed with untreated cloves.
– IND-SC-E: Indonesian-blended cigarette representative of
kretek cigarettes with the addition of 370 mg spent cloves
where eugenol had been added back to a concentration of
approximately 90% compared to untreated cloves.
– 2R4F: American-blended standard reference cigarette
obtained from the University of Kentucky (Davis and
Vaught, 1990).
Set 1 and Set 2 cigarettes were evaluated in two separate inha-
lation studies. Set 1 cigarettes were assessed in a 35-day inhalation
study in female rats with particular attention to histopathology of
the respiratory tract and inﬂammatory cells in the bronchoalveolar
lavage ﬂuid (BALF).
Set 2 cigarettes were evaluated in a 90-day inhalation study in
male and female rats and this study also included a chemokine/
cytokine proﬁle of BALF determined after 90 days of exposure (Per-
bio Science, Erembodegem, Belgium). The following chemokines/
cytokines were analyzed: Fractalkine, GRO, MCP1, MIPa, MIP2,MIP3a, RANTES, IL1a, IL1b, IL2, IL4, IL6, IL10, TNFa, IFNc, and
GM-CSF.2.3. Exposure
MS was generated according to ISO standard 3308 and 4387
(ISO, 1991a,b) on a 30-port rotary smoking machine and diluted
with ﬁltered conditioned air to the speciﬁed concentration of
TPM. Regular analysis of the test atmosphere ensured consistent
and reproducible delivery of MS.
Outbred male and female Sprague–Dawley rats (Crl: CDBR)
were exposed nose-only in restrainer tubes to the test atmosphere.
Sham-exposed rats were exposed to ﬁltered, conditioned air only
applying the same exposure regimen as used for the smoke
exposed rats. Smoke exposed rats were exposed either for 35
consecutive days, 7 days/week, 2 times 1 h/day with a break of
30 min to a TPM concentration of approximately 600 lg/l from
Set 1 cigarettes with and without the addition of eugenol (female
rats only) or for 90 consecutive days, 7 days/week, 6 h/day to a
TPM concentration of approximately 200 lg/l from Set 2 cigarettes
with and without the addition of clove components (male and
female rats). There was a postinhalation period of 42 days to
investigate the reversibility, persistence, or delayed occurrence of
smoke-related effects.2.4. Endpoints
The 35-day inhalation study focused on a detailed histopathol-
ogy of the respiratory tract, ﬂow cytometric analyses of free lung
cells obtained by lung lavage, respiratory parameters, and nicotine
metabolites.
The 90-day study included all parameters speciﬁed in the OECD
guideline 413 for inhalation toxicity studies (OECD, 1981).
However, beside effects, local responses in the respiratory tract
towards the smoke exposure, were the main focus of this study.2.5. Data evaluation and statistics
As descriptive statistics, the number of values, the arithmetic
mean, and the standard error or interquartile range were given
for continuous biological data, whereas for chemical–analytical
or physical data describing the test atmosphere, the standard
deviation (SD) was calculated.
Set 1 cigarettes (35-day inhalation study)
Statistical analysis was performed to detect signiﬁcant differ-
ences between all treated groups relative to sham and US-0. For
continuous data, a 1-way ANOVA was applied for overall compar-
ison followed by the Dunnett post hoc test and was carried out
either on log- or non-transformed data. For ordinal data, the
Cochran–Mantel–Haenszel test was applied for both overall and
pairwise comparison.
Set 2 cigarettes (90-day inhalation study)
All comparisons were made on equal TPM basis. Statistical
analysis was performed to detect signiﬁcant differences between
exposure groups and sham, and between the following pairs:
(1) Effect of different tobacco blends: Comparison of US-C vs.
IND-C.
(2) Effect of cut clove: Comparison of IND vs. IND-C.
(3) Effect of spent clove: Comparison of IND-C and IND vs.
IND- SC.
(4) Effect of add-back of oleoresin: Comparison of IND-C and
IND-SC vs. IND-SC-O.
(5) Effect of add-back of eugenol: Comparison of IND-C, IND-SC
and IND-SC-O vs. IND-SC-E.
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standard error (SE) and the incidences were given. The Cochran–
Mantel–Haenszel test was applied for ordinal data (overall and
pairwise comparison) and the v2 test was applied for both overall
and pairwise comparison. For continuous data, statistical testing
was carried out on log- and non-transformed data. A t-test was
used for (1) and (2) whereas a 1-way analysis of variance (ANOVA)
was applied for overall comparison of the other pairs, followed by
the Dunnett post hoc test.
3. Results
3.1. Effect of eugenol added to American-blended cigarettes (35-day
inhalation study)
The inﬂuence of eugenol added to cigarette ﬁller on the lung
inﬂammatory activity and on histopathological results in the respi-
ratory tract was investigated in a 35-day inhalation study in female
rats.
3.1.1. Test atmosphere characterization
The target TPM concentration of 600 lg/l was achieved for all
smoke groups and the particle size for the US-0, US-2.5, US-5,
and US-10 cigarettes was similar (Table 1). The eugenol concentra-
tion in smoke from the cigarettes with 2.5% eugenol cigarette was
similar to the marketed kretek cigarette Garam, however, the
nicotine, carbon monoxide (CO), acetaldehyde, and acrolein con-
centration were generally lower in Garam than American-blended
cigarettes with added eugenol or in the reference cigarette 2R4F. A
full analysis of smoke constituents from these cigarettes can be
found in Part 4 of this series (Roemer et al., 2014b).
3.1.2. Clinical observations and body weight development
Observations of nasal discharge, closed eyelids, and trembling
were made in all animals exposed to cigarette smoke. These
observations vanished always within 30 min after the end of the
exposure. They have also been made in previous inhalation studies
of MS (Vanscheeuwijck et al., 2002) and reﬂect exposure condi-
tions, the irritative capacity of MS, and the pharmacological action
of nicotine. There were no differences between the treatment
groups. No effects on bodyweight gain were observed in any of
the exposure groups. The absence of a smoke effect on bodyweight
in female rats has also been observed in previous studies with MS
(Gaworski et al., 2010). Furthermore, as the study was limited to
35 days the impact on bodyweight would be limited.
3.1.3. Respiratory physiology
A reduction of tidal volume, respiratory minute volume, and
peak inspiratory ﬂow by up to approximately 40% was seen in all
smoke-exposed groups compared to the sham exposure group.
The tidal volume was statistically signiﬁcantly decreased in treat-
ment groups US-2.5, US-5, and US-10 relative to US-0 by 19%,
18%, and 33%, respectively.
3.1.4. Carboxyhemoglobin
The mean concentrations of carboxyhemoglobin were between
27% and 33% for the groups exposed to the experimental cigarettes,
15% for the Garam group, and 35% for the reference cigarette 2R4F
group.
3.1.5. Urinary nicotine metabolites
The relative metabolic proﬁle of nicotine was similar in all
smoke-exposed groups regarding the relative amounts of the
nicotine metabolites nicotine-N0-oxide, nornicotine, cotinine,
30-hydroxycotinine, 50-hydroxycotinine, norcotinine, 3-(3-pyridyl)-4-oxobutyric acid, 4-(3-pyridyl)-4-hydroxybutyric acid, and
3 pyridylacetic acid. The total amount of nicotine metabolites in
urine excreted over a 24 h period correlated with the concentration
of nicotine in the inhalation chamber (data not shown).
3.1.6. Organ weight
There was no impact on absolute organ weights in rats exposed
to MS from cigarettes containing different levels of eugenol com-
pared to the group without addition of eugenol (data not shown).
However, thymus weight was decreased by approximately 35%
and weight of adrenals was increased by approximately 25% rela-
tive to the sham control with no apparent differences within all
smoke exposed groups.
3.1.7. Cell count in BALF
There was a statistically signiﬁcant increase by approximately
40% in the absolute number of cells (all cell types) in BALF relative
to sham exposure in all groups exposed to MS (Table 2). This
increase was slightly lower in cigarettes with added eugenol but
was not dose-dependent and only reached statistical signiﬁcance
for US-2.5 and US-10. The lowest response among smoke-exposed
groups was observed in animals exposed to smoke from Garam
while the reference cigarette 2R4F gave a similar response as the
US-0 cigarette. The absolute number of neutrophils, however,
was increased by a factor of approximately 100 in the US-0 and
the reference cigarette 2R4F group. This increase was much lower
in the groups with the addition of eugenol, where a eugenol depen-
dent attenuation of the effect could be observed. At the highest
addition level the increase compared to sham was by a factor of
35. For the Garam cigarette, the increase in neutrophils was even
lower, i.e., by a factor of 5. There was also a slight decrease in
number of lymphocytes in US-2.5, US-5 and US-10 cigarettes
relative to US-0 but this decrease was not statistically signiﬁcant.
3.1.8. Histopathology of respiratory tract
The histopathological changes at nose level 1–4, larynx, trachea/
bifurcation, and left lung are consistent with previous inhalation
studies ofmainstream cigarette smoke fromAmerican-blended cig-
arettes (e.g., (Friedrichs et al., 2006; Vanscheeuwijck et al., 2002).
There was a reduction by the addition of eugenol in severity of
the histopathological endpoints of nose and lung (Tables 3 and 4).
This effect was mostly dose-dependent and reached statistical sig-
niﬁcance. At the deeper parts of the nose (level 3–4), most histopa-
thological changes observed in the US-0 cigarette-exposed group
were not observed for any of the groups exposed to smoke from
the cigarettes containing different levels of eugenol (Table 4). A
dose-dependent effect of eugenol at the larynx was not observed.
Histopathological effects induced by smoke from the reference cig-
arette 2R4F and the US-0 cigarette were in a similar range. There
were also only slight differences between the histopathological
effects between the US-10 and Garam group; the Garam group
being somewhat less responsive to the smoke exposure (Table 3).
3.2. Effects of clove components (90-day inhalation study)
The inﬂuence of tobacco blend, cut cloves, spent cloves, add-
back of oleoresin, and add-back of eugenol was evaluated in a
90-day inhalation study in rats.
3.2.1. Test atmosphere characterization
The target concentration of 200 lg TPM/l was achieved for all
smoke-exposed groups and with particle sizes being in the respira-
ble size range (Table 5). As expected, eugenol could not be detected
in MS from the reference cigarette 2R4F and the Indonesian-
blended cigarette with no cloves added. Eugenol was also
signiﬁcantly reduced (75%) in MS from cigarettes with spent
Table 1
Test atmosphere in exposure chamber (35-day inhalation study).
Group TPM (lg/l)
(N = 35)
MMAD (lm)
(N = 1)
GSD (lm) Eugenol (lg/l)
(N = 4–5)
Nicotine
(lg/l) (N = 8)
Carbon monoxide (ppm) Acetaldehyde
(lg/l) (N = 5–7)
Acrolein (lg/l)
(N = 5–7)
Formaldehyde
(lg/l) (N = 5–7)
Sham <6.7 – – <0.5 <0.03 <4.5 – – –
US-0 590.3 ± 32.3 0.59 1.67 <0.5 56.7 ± 4.84 656.2 ± 27.4 25.6 ± 0.54 1.85 ± 0.04 0.53 ± 0.05
US-2.5 601.5 ± 35.4 0.57 1.68 72.7 ± 7.7 53.7 ± 3.41 594.2 ± 36.3 23.8 ± 2.26 1.64 ± 0.15 0.53 ± 0.07
US-5 601.1 ± 26.0 0.58 1.67 139.5 ± 8.4 50.0 ± 2.51 548.5 ± 26.0 20.8 ± 1.23 1.42 ± 0.09 0.48 ± 0.05
US-10 582.0 ± 31.4 0.59 1.69 217.4 ± 12.1 42.0 ± 1.29 492.2 ± 26.5 17.4 ± 0.23 1.20 ± 0.04 0.57 ± 0.08
Garam 579.8 ± 32.0 0.70 1.73 70.5 ± 9.7 31.2 ± 3.38 233.3 ± 13.0 7.33 ± 0.48 0.75 ± 0.06 0.71 ± 0.09
2R4F 588.9 ± 29.9 0.58 1.67 <0.5 48.3 ± 2.05 646.0 ± 32.5 25.2 ± 0.99 1.92 ± 0.06 0.60 ± 0.04
Remarks: US-x, x gives eugenol addition (%) to the ﬁller of the cigarettes; results represent medians or means ± standard deviation; MMAD, Mass Median Aerodynamic
Diameter; GSD, Geometrical Standard Deviation; TPM, total particulate matter; N, number of determinations.
Table 2
Differential cell count in BALF after the 35-day inhalation exposure; comparison of US-10, US-5, and US-2.5 groups to sham and US-0 groups.
Cell type Sham 2R4F Garam US-0 US-2.5 US-5 US-10
All cell types 34.1 ± 4.0 54.9 ± 2.7 43.8 ± 4.0 60.8 ± 5.8 52.6 ± 6.4 53.5 ± 6.3 53.5 ± 5.7
Neutrophils 0.11 ± 0.02 10.5 ± 1.23 0.54 ± 0.15 11.1 ± 1.41 4.76 ± 0.91⁄ 6.36 ± 1.74 3.75 ± 0.82⁄⁄
Alveolar macrophages 33.6 ± 4.0 43.8 ± 2.0 42.8 ± 3.9 48.9 ± 5.9 47.2 ± 6.4 46.5 ± 5.5 49.1 ± 5.1
Lymphocytes 0.36 ± 0.07 0.67 ± 0.05 0.41 ± 0.08 0.84 ± 0.14 0.64 ± 0.13 0.58 ± 0.10 0.64 ± 0.14
Remarks: US-x, x gives eugenol addition (%) to the ﬁller of the cigarettes; results are presented as mean ± standard error; cell numbers reported as 105 cells/lung; numbers in
bold are statistically different from sham at p 6 0.001; ⁄ and ⁄⁄ indicate statistically signiﬁcantly differences to US-0 at p 6 0.05 and p 6 0.001, respectively; Garam and 2R4F
were only evaluated relative to sham.
Table 3
Histopathological ﬁndings in the respiratory tract of female rats after the 35-day inhalation period to MS of US-0, US-2.5, US-5, and US-10 cigarettes.
Localization Tissue type Observation US-0 US-2.5 US-5 US-10 Garam 2R4F
Nose Level 1 Respiratory
epithelium
Squamous metaplasia with
corniﬁcation
2.8 ± 0.210/10 1.6 ± 0.38/10⁄⁄ 1.3 ± 0.38/10⁄⁄ 0.0 ± 0.00/10⁄⁄⁄ 0.4 ± 0.23/10 1.8 ± 0.49/10
Squamous metaplasia
without corniﬁcation
4.0 ± 0.010/10 4.0 ± 0.010/10 3.6 ± 0.310/10 2.0 ± 0.410/10 ⁄⁄ 2.1 ± 0.410/10 3.8 ± 0.210/10
Nose Level 2 Respiratory
epithelium
Reserve cell hyperplasia 3.6 ± 0.210/10 2.9 ± 0.310/10 2.9 ± 0.310/10⁄ 0.7 ± 0.35/10⁄⁄⁄ 0.2 ± 0.12/10 2.9 ± 0.49/10
Squamous metaplasia
without corniﬁcation
0.9 ± 0.27/10 0.2 ± 0.12/10⁄ 0.2 ± 0.12/10⁄ 0.0 ± 0.00/10⁄⁄ 0.0 ± 0.00/10 0.4 ± 0.23/10
Olfactory
epithelium
Atrophy 3.3 ± 0.79/10 1.5 ± 0.56/10⁄ 0.6 ± 0.43/10⁄⁄ 0.4 ± 0.32/10⁄⁄ 0.0 ± 0.00/10 2.2 ± 0.66/10
Squamous metaplasia
without corniﬁcation
2.2 ± 0.66/10 0.8 ± 0.52/10 0.4 ± 0.41/10⁄ 0.0 ± 0.00/10⁄⁄ 0.0 ± 0.00/10 1.2 ± 0.63/10
Olfactory region Loss of nerve bundles 2.8 ± 0.87/10 1.1 ± 0.54/10 0.4 ± 0.41/10⁄⁄ 0.3 ± 0.31/10⁄⁄ 0.0 ± 0.00/10 1.7 ± 0.56/10
Nose Level 3 Olfactory
epithelium
Atrophy 1.8 ± 0.74/9 0.0 ± 0.00/10⁄ 0.4 ± 0.41/10 0.2 ± 0.21/10 0.0 ± 0.00/10 1.2 ± 0.60/10
Squamous metaplasia
without corniﬁcation
1.8 ± 0.74/9 0.0 ± 0.00/10⁄ 0.4 ± 0.41/10 0.2 ± 0.20/10⁄ 0.0 ± 0.00/10 1.2 ± 0.60/10
Olfactory region Loss of nerve bundles 1.0 ± 0.44/9 0.0 ± 0.00/10⁄ 0.2 ± 0.21/10 0.1 ± 0.11/10 0.0 ± 0.00/10 0.5 ± 0.32/10
Nose Level 4 Olfactory
epithelium
Atrophy 2.0 ± 0.75/10 0.0 ± 0.00/10⁄ 0.4 ± 0.41/10 0.2 ± 0.21/10⁄ 0.0 ± 0.00/10 0.8 ± 0.52/10
Squamous metaplasia
without corniﬁcation
2.0 ± 0.75/10 0.0 ± 0.00/10⁄ 0.4 ± 0.41/10 0.2 ± 0.20/10⁄ 0.0 ± 0.00/10 0.8 ± 0.52/10
Olfactory region Loss of nerve bundles 1.4 ± 0.55/10 0.0 ± 0.00/10⁄⁄ 0.1 ± 0.11/10⁄ 0.0 ± 0.00/10⁄ 0.0 ± 0.00/10 0.3 ± 0.22/10
Larynx ﬂoor Pseudo-stratiﬁed
epithelium
Squamous metaplasia with
corniﬁcation
4.7 ± 0.210/10 2.9 ± 0.49/10⁄⁄ 4.6 ± 0.210/10 4.2 ± 0.410/10 3.9 ± 0.410/10 4.4 ± 0.310/10
Tracheal bifurcation Respiratory
epithelium
Goblet cell hyperplasia 1.0 ± 0.28/10 0.6 ± 0.33/10 1.2 ± 0.28/9 0.4 ± 0.24/10⁄ 0.7 ± 0.26/10 0.7 ± 0.26/10
Left lung Respiratory
epithelium
Goblet cell hyperplasia 2.8 ± 0.49/9 1.9 ± 0.37/7 2.0 ± 0.57/8 1.1 ± 0.47/10⁄⁄ 1.8 ± 0.67/9 2.8 ± 0.67/8
Alveoli Pigmented alveolar
macrophages
0.8 ± 0.26/10 0.7 ± 0.35/10 0.2 ± 0.12/10 0.1 ± 0.11/10⁄ 0.0 ± 0.00/10 0.9 ± 0.27/10
Remarks: US-x, x gives eugenol addition (%) to the ﬁller of the cigarettes; only histopathological endpoints statistically different from US-0 are included; results are
represented as mean scores ± standard errors and incidences; comparison to US-0: ⁄, ⁄⁄, and ⁄⁄⁄ indicate statistically different from US-0 at p 6 0.05, p 6 0.01, and p 6 0.001,
respectively.
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atmosphere and the highest concentrations were generally seen
with the reference cigarette 2R4F. A detailed analysis on the smokechemistry of these cigarette types is summarized in Part 4 of this
series (Roemer et al., 2014b) and conﬁrmed the observations from
this study.
Table 4
Histopathological ﬁndings in the respiratory tract of female rats after the 35-day inhalation period to MS of US-0, US-2.5, US-5, and US-10 cigarettes (endpoints reported as
incidence only).
Localization Tissue type Observation US-0 US-2.5 US-5 US-10
Nose Level 2 Olfactory epithelium Ulceration 4/10 0/10⁄ 0/10⁄ 0/10⁄
Lamina propria Inﬂammatory cell inﬁltration 5/10 0/10⁄⁄ 0/10⁄⁄ 0/10⁄⁄
Nose Level 3 Olfactory epithelium Ulceration 3/9 0/10⁄ 0/10⁄ 0/10⁄
Lamina propria Inﬂammatory cell inﬁltration 3/9 0/10⁄ 0/10⁄ 0/10⁄
Lumen Red blood cells 3/9 0/10⁄ 0/10⁄ 0/10⁄
Remarks: US-x, x gives eugenol addition (%) to the ﬁller of the cigarettes; only histopathological endpoints statistically signiﬁcantly different from US-0 are included;
comparison to US-0: ⁄: p 6 0.05, ⁄⁄: p 6 0.01, ⁄⁄⁄: p 6 0.001.
Table 5
Test atmosphere in exposure chamber of 90-day inhalation study.
Group TPM lg/l
(N = 92)
Particle
size(N = 2)
Eugenol (lg/l)
(N = 12)
Nicotine (lg/l)
(N = 15)
Carbon monoxide
(ppm) (N = 92)
Acetaldehyde
(lg/l) (N = 11–13)
Acrolein (lg/l)
(N = 11–13)
Formaldehyde (lg/l)
(N = 11–13)
MMAD (lm) GSD
Sham <1.5 – – – <0.03 <4.5 – – –
2R4F 197.4 ± 8.4 0.71 1.70 0.0 ± 0.0 15.1 ± 1.12 234.6 ± 14.1 11.9 ± 0.96 1.19 ± 0.11 0.30 ± 0.02
IND-C 197.2 ± 8.0 0.83 1.73 22.2 ± 1.2 12.4 ± 0.85 127.3 ± 5.5 5.51 ± 0.44 0.72 ± 0.06 0.38 ± 0.04
US-C 201.1 ± 7.5 0.79 1.74 21.7 ± 1.6 14.8 ± 0.95 136.8 ± 5.3 6.96 ± 0.44 0.82 ± 0.05 0.34 ± 0.04
IND 195.4 ± 8.5 0.88 1.70 0.0 ± 0.0 17.9 ± 1.42 152.2 ± 5.9 7.55 ± 0.25 0.88 ± 0.03 0.39 ± 0.01
IND-SC 197.1 ± 7.0 0.77 1.72 5.2 ± 0.3 17.0 ± 1.06 153.8 ± 6.9 7.67 ± 0.40 1.00 ± 0.05 0.50 ± 0.03
IND-SC-O 200.4 ± 7.8 0.86 1.73 21.5 ± 1.2 14.9 ± 1.06 130.4 ± 5.5 6.42 ± 0.32 0.85 ± 0.04 0.47 ± 0.03
IND-SC-E 198.5 ± 8.6 0.85 1.69 20.3 ± 2.0 15.3 ± 0.95 142.5 ± 7.1 6.85 ± 0.50 0.90 ± 0.05 0.47 ± 0.05
Remarks: results represent medians or means ± standard deviation; MMAD, Mass Median Aerodynamic Diameter; GSD, Geometrical Standard Deviation; TPM, total par-
ticulate matter; N, number of determinations.
Fig. 1. Body weight development of male rats during the 90-day inhalation study.
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Clinical observations consistent with previous inhalation stud-
ies were made and are considered related to tube restraint, the
pharmacological action of nicotine and/or the irritative capacity
of cigarette smoke. These effects vanished within 30 min after
the end of the daily exposures. Effects included Harderian gland
secretion and wet fur, sporadic nasal discharge, closed eyelids,
altered levels of activity, increased reaction to sound and touch,
decreased gripping ability and decreased turning reﬂex. There
were no differences that could clearly be related to the experimen-
tal cigarette type.3.2.3. Body weight
Body weight was statistically signiﬁcantly lower in male rats
exposed to cigarette MS relative to sham exposed animals at the
end of the 90-day exposure period (Fig. 1). There was less impact
on body weight development in the female rats as has also beenobserved in previous inhalation studies of MS (Gaworski et al.,
2009). The mean food consumption relative to body weight for
all smoke exposed groups was comparable to the sham group for
both sexes. A difference between cigarette types was not observed.
3.2.4. Clinical chemistry
Differences in clinical chemistry data in the smoke exposed
groups compared to the sham related to a decrease in cholesterol
and triglycerides. Both effects were not dependent on the cigarette
type related (data not shown).
3.2.5. Respiratory physiology
The respiratory frequency, tidal volume, peak inspiratory ﬂow,
and minute volume of most male and female smoke-exposed
groups were statistically signiﬁcantly lower compared to the sham
group. Most decreases were up to 20%. There was a difference
between the smoke-exposed groups for tidal volume and minute
volume of male animals exposed to MS from the IND-C cigarette
being statistically signiﬁcantly higher than in animals exposed to
MS from the IND, IND-SC, and IND-SC-O cigarettes. The peak inspi-
ratory ﬂow of these rats was also higher when compared to IND
and IND-SC-O smoke-exposed animals (data not shown).
3.2.6. Urinary nicotine metabolites
The metabolic proﬁle of urinary nicotine metabolites (nicotine-
N0-oxide, nornicotine, cotinine, 30-hydroxycotinine, 50-hydroxycot-
inine, norcotinine) was similar in all smoke-exposed groups and
the total nicotine metabolite excretion correlated with concentra-
tion of nicotine in the test atmosphere; male and female animals
exposed to MS from the IND-SC-O cigarettes, and females of group
IND-SC-E were similar to the IND-C exposed group and excreted
less nicotine metabolites than the other groups (Fig. 2).
3.2.7. Carboxyhemoglobin
In the smoke-exposed groups (males and females), the mean
steady-state blood carboxyhemoglobin concentration ranged
Fig. 2. Total amount of nicotine metabolites excreted in urine Remarks: sample collection over 24 h, determined once during the 90-day inhalation period from male and
female rats, nicotine concentration in test atmosphere, regression line for all groups, mean ± standard error.
Table 6
Differential cell count in broncho alveolar ﬂuid (comparison to sham) after 90-day inhalation exposure.
Cell type Gender Cigarette
Sham IND IND-C US-C IND-SC IND-SC-O IND-SC-E
All cell types M 58.6 ± 6.07 175.5 ± 14.8⁄⁄⁄ 121.9 ± 14.3⁄⁄⁄ 118.8 ± 9.35⁄⁄⁄ 96.8 ± 8.68⁄⁄ 112.6 ± 11.6⁄⁄⁄ 86.1 ± 4.24⁄
F 44.2 ± 2.96 197.5 ± 11.6⁄⁄⁄ 94.4 ± 11.3⁄⁄⁄ 102.6 ± 7.27⁄⁄⁄ 101.4 ± 7.38⁄⁄⁄ 108.6 ± 8.48⁄⁄⁄ 86.1 ± 7.01⁄⁄⁄
Neutro-phils M 0.48 ± 0.08 38.83 ± 5.09⁄⁄⁄ 19.9 ± 4.92⁄⁄⁄ 21.3 ± 5.03⁄⁄⁄ 15.9 ± 2.81⁄⁄⁄ 12.7 ± 1.76⁄⁄⁄ 9.04 ± 1.11⁄⁄⁄
F 0.25 ± 0.06 68.75 ± 6.24⁄⁄⁄ 17.8 ± 4.09⁄⁄⁄ 25.9 ± 5.53⁄⁄⁄ 20.9 ± 3.23⁄⁄⁄ 21.7 ± 3.29⁄⁄⁄ 14.1 ± 1.62⁄⁄⁄
Alveolar macro-phages M 57.3 ± 5.94 134.0 ± 10.9⁄⁄⁄ 100.4 ± 12.6⁄⁄ 95.7 ± 8.11⁄⁄ 80.0 ± 6.54 98.7 ± 11.3⁄⁄ 76.1 ± 4.29
F 43.5 ± 2.89 125.6 ± 7.84⁄⁄⁄ 75.2 ± 8.05⁄⁄⁄ 75.6 ± 6.19⁄⁄⁄ 79.3 ± 7.42⁄⁄⁄ 85.8 ± 7.67⁄⁄⁄ 70.8 ± 6.71⁄⁄
Lympho-cytes M 0.76 ± 0.12 2.65 ± 0.29⁄⁄⁄ 1.61 ± 0.35⁄ 1.84 ± 0.32⁄⁄ 0.93 ± 0.16 1.21 ± 0.15 1.00 ± 0.11
F 0.40 ± 0.05 3.19 ± 0.27⁄⁄⁄ 1.48 ± 0.29⁄⁄⁄ 1.18 ± 0.12⁄⁄⁄ 1.19 ± 0.11⁄⁄⁄ 1.18 ± 0.12⁄⁄⁄ 1.12 ± 0.13⁄⁄⁄
Remarks: Cell numbers reported as 105 cells/lung; results are presented as mean ± standard error; M, male; F, female; ⁄, p 6 0.05; ⁄⁄: p 6 0.01; ⁄⁄⁄, p 6 0.001 statistically
signiﬁcant from sham.
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uptake of gas phase components.3.2.8. Hematology
No signiﬁcant differences between the smoke-exposed groups
or between the smoke-exposed groups and sham-exposed group
were observed for any of these parameters. There was a statisti-
cally signiﬁcant increase in neutrophil count for some smoke-Table 7
Differential cell count in broncho alveolar ﬂuid (pairwise statistical evaluation) after 90-d
Cell type Gender Pairwise statistical comparison (effect of t
(1) Effect oftobacco
blend
(2) Effect of cut
cloves
All cell types M IND"⁄
F IND"⁄⁄⁄
Neutrophils M IND"⁄
F IND"⁄⁄⁄
Alveolar macro-phages M
F IND"⁄⁄⁄
Lymphocytes M IND"⁄
F IND"⁄⁄⁄
Remarks: signiﬁcant changes are represented by "(increase) and ; (decrease) at ⁄: p 6 0exposed groups relative to sham but no difference between exper-
imental cigarette types.3.2.9. Cell count in BALF
All smoke-exposed animals had a statistically signiﬁcant
increase in total BALF cells (alveolar macrophages, neutrophils,
and lymphocytes) relative to the sham group (Table 6). As the main
indicator of lung inﬂammation, the neutrophil count was signiﬁ-
cantly increased in all smoke-exposed groups up to a factor ofay inhalation exposure.
reatment)
(3) Effect ofspent
cloves
(4) Effect of add-back
of oleoresin
(5) Effect of add-back
of eugenol
IND"⁄⁄⁄
IND"⁄⁄⁄
IND"⁄⁄ IND-C"⁄
IND"⁄⁄⁄
IND"⁄⁄⁄
IND"⁄⁄⁄
IND"⁄⁄⁄
IND"⁄⁄⁄
.05, ⁄⁄: p 6 0.01, ⁄⁄⁄: p 6 0.001; M, males; F, females.
Fig. 3. Amounts of pro-inﬂammatory fractalkine, MIP-1a, and MCP1 in broncho alveolar ﬂuid Remarks: Data are reported as median with interquartile range. Solid lines
indicate differences (p < 0.05) to sham. Dashed lines indicate differences (p < 0.05) between experimental cigarettes.
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alveolar macrophages. These effects were generally more pro-
nounced in female rats. The addition of cut (IND-C) or spent cloves
(IND-SC) distinctly and statistically signiﬁcantly reduced the abso-
lute number of neutrophils and alveolar macrophages relative to
cigarettes consisting of an Indonesian blend only (IND) (Tables 6
and 7). Cigarettes with cloves added and only differing in the blend
type (American or Indonesian) were not signiﬁcantly different.
Add-back of oleoresin to cigarettes with spent cloves did not
change the inﬂammatory response relative to cigarettes with
cloves and spent cloves while add-back of eugenol further reduced
the inﬂammatory response (male rats only) as demonstrated by areduction in the absolute neutrophil count relative to IND-C
cigarettes.
The absolute neutrophil count in animals following a 42-day
recovery period was generally reduced >80% relative to what was
observed after 90-day exposure in most smoke-exposed groups.
However, with the exception of male animals exposed to IND-SC,
IND-SC-O, and IND-SC-E, all smoke-exposed groups were still sig-
niﬁcantly elevated relative to sham. The relative differences
between the smoke-exposed groups were generally also similar
as to what was observed after 90-days of exposure with the excep-
tion of a difference between the US-C and IND-C smoke-exposed
groups (US-C group had a higher total BALF cell and alveolar
E. Roemer et al. / Regulatory Toxicology and Pharmacology 70 (2014) S54–S65 S61macrophage count relative to IND-C group) which reached statisti-
cal signiﬁcance (data not shown).
3.2.10. Inﬂammatory molecular markers in BALF
A smoke exposure-related response was only observed for a
subset of the chemokines/cytokines evaluated (see Fig. 3). In
particular, a consistent increase in response to cigarette smoke
was only observed for fractalkine, MIP1a, and MCP1. Expression
of fractalkine was not inﬂuenced by the composition of the
experimental cigarettes, while addition of cut or spent cloves to
Indonesian tobacco signiﬁcantly lowered levels of MIP1a and
MCP1 in BALF. Moreover, the origin of the tobacco blend did not
inﬂuence the inﬂammatory markers.
3.2.11. Histopathology and weight of non-respiratory tract organs
There were slight, but statistically signiﬁcant, changes in weight
of certain organs relative to body weight, including, testis, adrenal
gland, kidney, thymus, and brain in all smoke-exposed groups
relative to sham treated animals. Mainly, these ﬁndings are consid-
ered either incidental or due to the reduced body weight as an
effect of smoke exposure. In male animals, the type of cigarette
had no impact on organ weights. Thymus weight from female
animals exposed to MS from IND-C cigarettes was statistically
lower than animals exposed to MS from IND-SC-O cigarettes and
higher than animals exposed to MS from IND-SC cigarettes.
The only corresponding histopathological ﬁnding in non-respi-
ratory organs was involution of the thymus. This was observed in
all smoke-exposed animals. There were minor differences in this
response between the different cigarette types, however these
differences are considered incidental and not biologically relevant.
3.2.12. Histopathology of respiratory tract
Histopathological observations (hyperplasia, metaplasia, and
atrophy) were qualitatively similar to previous inhalation studies
of mainstream cigarette smoke from American-blended cigarettes
and with the comparative assessment of the reference cigarette
2R4F, Garam, and the Kretek-R cigarette in this publication series
(Piadé et al., 2014b). Smoke-exposed male rats showed a response
in most histopathological endpoints relative to sham but there was
no statistically signiﬁcant difference in severity between the
cigarette groups at the end of the 90-day inhalation period. The
only exception was slightly reduced squamous metaplasia of
respiratory epithelium at nose level 1 in animals exposed to MS
from IND-C cigarettes relative to that from IND and US-C
cigarettes. The response in female animals was generally more
severe than in male animals (Tables 7–9).
Adding cloves to an Indonesian-blended cigarette distinctly and
statistically signiﬁcantly reduced the histopathological changes in
the lung. This cigarette type was associated with a reduced severity
of histopathological changes in the larynx (metaplasia) and lung
(nests of pigmented macrophages), but no difference of biological
relevance in the upper respiratory tract was observed. When cloves
were added to a cigarette with an American blend, there was no
signiﬁcant difference to Indonesian-blended cigarettes with cloves,
effectively demonstrating no impact of tobacco blend type on
severity of the histopathological endpoints.
Smoke from cigarettes with spent cloves demonstrated a higher
irritation potential in the upper respiratory tract (nose level 2–4)
than Indonesian-blended cigarettes with and without whole
cloves. However, addition of spent cloves was associated with
reduced severity of histopathological endpoints in the larynx and
lung compared to Indonesian-blended cigarettes with and without
whole cloves. Add-back of oleoresin and eugenol to cigarettes with
spent cloves reduced the severity of histopathological ﬁndings in
the upper respiratory tract (with the exception of olfactory epithe-
lial cell metaplasia at nose level 4) to similar levels as observed inanimals exposed to smoke from IND-C cigarettes. The severity of
nearly all histopathological ﬁndings found after the inhalation
period was reduced after the post-inhalation period with the rela-
tive amount of recovery being comparable for all smoke-exposed
groups (data not shown).4. Discussion
Kretek cigarettes differ from American-blended cigarettes pri-
marily by inclusion of cloves and the tobacco blend. As the analysis
of smoke constituents demonstrated (Piadé et al., 2014a), these
characteristics have an impact on smoke chemistry. To further
investigate the ﬁndings seen in the studies of Garam and the
Kretek-R cigarettes relative to the reference cigarette 2R4F, the
impact on the in vivo toxicity of adding eugenol to an American-
blended cigarette and of adding cut cloves to American- and
Indonesian-blended cigarettes was assessed. Additional studies
were also performed to determine the impact of extracting and
replacing essential oils from clove.
Set 1: Effect of different tobacco blends
The inﬂuence of blend type was assessed in this study by com-
paring Indonesian- (representative of marketed kretek cigarette)
and American-blended cigarettes with added cloves. Chemical
analysis of the inhalation atmosphere in the exposure chamber
demonstrated similar concentrations of eugenol and of the smoke
constituents acetaldehyde, acrolein, CO, and formaldehyde, which
also reﬂected the results from the extended smoke chemistry study
(Roemer et al., 2014b). The impact of some differences in smoke
chemistry on biological endpoints in rats following 90-day
inhalation exposure, as presented here, was negligible; there was
no difference in inﬂammatory cell count in the lung, and only a
minor difference in severity at the nose level 1 in male animals,
i.e., squamous metaplasia with/without corniﬁcation was slightly
lower in the US-C smoke-exposed group relative to the IND-C
smoke-exposed group. The ﬁnding of similar levels of histopathol-
ogical changes indicating local irritation in the respiratory tract
is supported by the in vitro cytotoxicity study results, which
also did not demonstrate a difference in cytotoxicity between
Indonesian- or American-blended cigarettes with cloves (Roemer
et al., 2014b).The results of these studies indicate that the higher
cytotoxicity observed for the reference cigarette 2R4F when
compared to the Garam cigarette is not related to the blend type
but rather the presence of cloves (Piadé et al., 2014a). Thus, the
type of the tobacco blend did not inﬂuence the histopathological
or lung inﬂammatory effects after cigarette smoking.
Set 2: Effect of cut cloves
The comparison of the cigarette with an Indonesian blend with
and without added cloves (IND vs. IND-C) provided similar results
as a comparison of the Garam cigarette to the reference cigarette
2R4F. In both cases the lung inﬂammatory reaction and the sever-
ity of several histopathological endpoints in the respiratory tract
were distinctly reduced due to the presence of cut cloves in the
ﬁller.
Set 3: Effect of spent cloves
To identify which component(s) of the clove is responsible for
the observed effects, cloves were extracted with hot ethanol to
remove essential oils (=spent cloves, IND-SC). When spent cloves
were added to an Indonesian-blended cigarette, inﬂammation
was reduced to a level similar to cigarettes with cut cloves
(IND-C). If the anti-inﬂammatory action of eugenol was indeed
responsible for the reduced lung inﬂammation observed with
cigarettes containing cloves, extraction of the essential oils from
cloves would be expected to increase the inﬂammatory potential
of these cigarettes to a level similar to tobacco-only cigarettes
(IND). However, this was not observed despite a general increase
Table 8
Histopathological ﬁndings in the respiratory tract of female rats after the 90-day inhalation period to MS from IND-C, US-C, IND, IND-SC, IND-SC-O, and IND-SC-E cigarettes, or to air (sham) (comparison to sham), (mean score ± standard
error and incidence).
Localization Tissue type Observation Cigarette
Sham IND-C US-C IND IND-SC IND-SC-O IND-SC-E
Nose Level 1 Respiratory epithelium Reserve cell hyperplasia 0.5 ± 0.25/10 4.0 ± 0.010/10 ⁄⁄⁄ 3.8 ± 0.29/9⁄⁄⁄ 4.0 ± 0.010/10⁄⁄⁄ 4.0 ± 0.010/10⁄⁄⁄ 4.0 ± 0.010/10⁄⁄⁄ 4.0 ± 0.010/10⁄⁄⁄
Loss of goblet cells 0.1 ± 0.11/10 3.2 ± 0.210/10⁄⁄⁄ 3.1 ± 0.39/9⁄⁄⁄ 3.9 ± 0.310/10⁄⁄⁄ 3.3 ± 0.310/10⁄⁄⁄ 3.6 ± 0.210/10⁄⁄⁄ 3.2 ± 0.210/10⁄⁄⁄
Squamous metaplasia with corniﬁcation 0.0 ± 0.00/10 0.7 ± 0.27/10⁄⁄ 0.9 ± 0.36/9⁄⁄ 1.0 ± 0.28/10⁄⁄⁄ 0.8 ± 0.27/10⁄⁄ 0.7 ± 0.26/10⁄⁄ 1.0 ± 0.19/10⁄⁄⁄
Squamous metaplasia without corniﬁcation 0.0 ± 0.00/10 3.6 ± 0.310/10⁄⁄⁄ 3.6 ± 0.39/9⁄⁄⁄ 3.8 ± 0.210/10⁄⁄⁄ 3.6 ± 0.310/10⁄⁄⁄ 3.8 ± 0.210/10⁄⁄⁄ 3.8 ± 0.210/10⁄⁄⁄
Nose Level 2 Respiratory epithelium Reserve cell hyperplasia 0.0 ± 0.00/10 1.5 ± 0.29/10⁄⁄⁄ 1.4 ± 0.29/9⁄⁄⁄ 2.3 ± 0.310/10⁄⁄⁄ 2.4 ± 0.59/10⁄⁄⁄ 2.3 ± 0.49/10⁄⁄⁄ 2.3 ± 0.410/10⁄⁄⁄
Olfactory epithelium Atrophy 0.0 ± 0.00/10 2.0 ± 0.58/10⁄⁄⁄ 3.2 ± 0.58/9⁄⁄⁄ 3.2 ± 0.410/10⁄⁄⁄ 4.0 ± 0.010/10⁄⁄⁄ 3.3 ± 0.59/10⁄⁄⁄ 3.1 ± 0.510/10⁄⁄⁄
Squamous metaplasia without corniﬁcation 0.0 ± 0.00/10 1.6 ± 0.57/10⁄⁄ 3.0 ± 0.58/9⁄⁄⁄ 2.8 ± 0.59/10⁄⁄⁄ 3.8 ± 0.210/10⁄⁄⁄ 2.8 ± 0.58/10⁄⁄⁄ 2.2 ± 0.67/10⁄⁄
Olfactory region Loss of nerve bundles 0.0 ± 0.00/10 2.0 ± 0.58/10⁄⁄⁄ 3.2 ± 0.58/9⁄⁄⁄ 3.1 ± 0.59/10⁄⁄⁄ 4.0 ± 0.010/10⁄⁄⁄ 3.3 ± 0.59/10⁄⁄⁄ 3.1 ± 0.510/10⁄⁄⁄
Nose Level 3 Olfactory epithelium Atrophy 0.0 ± 0.00/10 1.5 ± 0.66/10⁄⁄ 2.6 ± 0.67/9⁄⁄⁄ 1.8 ± 0.65/10⁄ 3.6 ± 0.49/10⁄⁄⁄ 2.5 ± 0.67/10⁄⁄ 1.8 ± 0.65/10⁄
Squamous metaplasia without corniﬁcation 0.0 ± 0.00/10 1.3 ± 0.64/10⁄ 2.0 ± 0.67/9⁄⁄⁄ 1.7 ± 0.65/10⁄ 3.6 ± 0.49/10⁄⁄⁄ 2.2 ± 0.66/10⁄⁄ 1.7 ± 0.65/10⁄
Olfactory region Loss of nerve bundles 0.0 ± 0.00/10 1.5 ± 0.66/10⁄⁄ 2.6 ± 0.67/9⁄⁄⁄ 1.8 ± 0.65/10⁄⁄⁄ 3.6 ± 0.49/10⁄⁄⁄ 2.5 ± 0.67/10⁄⁄⁄ 1.8 ± 0.65/10⁄
Nose Level 4 Olfactory epithelium Atrophy 0.0 ± 0.00/10 1.3 ± 0.64/10⁄ 2.2 ± 0.75/9⁄⁄⁄ 1.4 ± 0.64/10⁄ 3.6 ± 0.49/10⁄⁄⁄ 2.1 ± 0.66/10⁄⁄ 1.4 ± 0.64/10⁄
Squamous metaplasia without corniﬁcation 0.0 ± 0.00/10 1.2 ± 0.63/10 1.8 ± 0.65/9⁄⁄ 1.0 ± 0.53/10 3.6 ± 0.49/10⁄⁄⁄ 1.9 ± 0.66/10⁄⁄ 1.3 ± 0.64/10⁄
Olfactory region Loss of nerve bundles 0.0 ± 0.00/10 1.3 ± 0.64/10⁄⁄ 2.2 ± 0.75/9⁄⁄ 1.4 ± 0.64/10⁄ 3.6 ± 0.49/10⁄⁄⁄ 2.1 ± 0.66/10⁄⁄ 1.4 ± 0.64/10⁄
Larynx Ventral depression Squamous metaplasia without corniﬁcation 0.4 ± 0.32/10 2.8 ± 0.410/10⁄⁄⁄ 3.0 ± 0.49/9⁄⁄⁄ 4.5 ± 0.310/10⁄⁄⁄ 3.6 ± 0.59/10⁄⁄⁄ 2.7 ± 0.410/10⁄⁄⁄ 3.0 ± 0.310/10⁄⁄⁄
Squamous metaplasia with corniﬁcation 0.0 ± 0.00/10 0.8 ± 0.53/10⁄ 0.8 ± 0.62/9⁄⁄⁄ 4.0 ± 0.59/10⁄⁄ 2.1 ± 0.76/10⁄⁄ 0.7 ± 0.43/10 0.8 ± 0.62/10
Vocal cords, LMR Hyperplasia without corniﬁcation 1.0 ± 0.47/10 4.0 ± 0.010/10⁄⁄⁄ 3.9 ± 0.19/9⁄⁄⁄ 4.0 ± 0.010/10⁄⁄⁄ 3.6 ± 0.49/10⁄⁄ 3.6 ± 0.49/10⁄⁄ 4.0 ± 0.010/10⁄⁄⁄
Hyperplasia with corniﬁcation 0.4 ± 0.41/10 4.5 ± 0.310/10⁄⁄⁄ 4.6 ± 0.39/9⁄⁄⁄ 4.8 ± 0.210/10⁄⁄⁄ 3.7 ± 0.69/10⁄⁄⁄ 4.4 ± 0.310/10⁄⁄⁄ 4.6 ± 0.210/10⁄⁄⁄
Vocal cords, UMR Squamous metaplasia without corniﬁcation 1.3 ± 0.47/8 4.2 ± 0.49/9⁄⁄ 4.6 ± 0.27/7⁄⁄ 4.9 ± 0.18/8⁄⁄⁄ 2.9 ± 0.86/7 3.7 ± 0.66/6⁄ 4.4 ± 0.27/7⁄⁄
Squamous metaplasia with corniﬁcation 0.1 ± 0.11/8 2.8 ± 0.86/9⁄ 3.0 ± 1.05/7⁄ 4.4 ± 0.58/8⁄⁄⁄ 1.9 ± 0.93/7 1.0 ± 0.63/6 3.4 ± 0.86/7⁄⁄
Pseudo-stratiﬁed epithelium Squamous metaplasia without corniﬁcation 1.0 ± 0.56/10 5.0 ± 0.010/10⁄⁄⁄ 5.0 ± 0.09/9⁄⁄⁄ 5.0 ± 0.010/10⁄⁄⁄ 4.5 ± 0.59/10⁄⁄ 5.0 ± 0.010/10⁄⁄⁄ 5.0 ± 0.010/10⁄⁄⁄
Squamous metaplasia with corniﬁcation 0.5 ± 0.51/10 5.0 ± 0.010/10⁄⁄⁄ 5.0 ± 0.09/9⁄⁄⁄ 5.0 ± 0.010/10⁄⁄⁄ 4.5 ± 0.59/10⁄⁄⁄ 5.0 ± 0.010/10⁄⁄⁄ 5.0 ± 0.010/10⁄⁄⁄
Vocal folds Epithelium Hyperplasia without corniﬁcation 0.4 ± 0.23/10 2.4 ± 0.310/10⁄⁄⁄ 2.0 ± 0.39/9⁄⁄ 1.9 ± 0.110/10⁄⁄⁄ 2.4 ± 0.310/10⁄⁄⁄ 2.2 ± 0.210/10⁄⁄⁄ 2.1 ± 0.210/10⁄⁄⁄
Hyperplasia with corniﬁcation 0.5 ± 0.51/10 3.6 ± 0.510/10⁄⁄⁄ 3.9 ± 0.59/9⁄⁄⁄ 4.7 ± 0.210/10⁄⁄⁄ 4.6 ± 0.310/10⁄⁄⁄ 4.6 ± 0.310/10⁄⁄⁄ 3.9 ± 0.69/10⁄⁄
Left lung Respiratory epithelium Goblet cell hyperplasia 0.4 ± 0.32/10 1.0 ± 0.27/9 1.1 ± 0.37/9⁄ 0.8 ± 0.17/9 1.7 ± 0.210/10⁄⁄ 1.7 ± 0.29/9⁄⁄ 1.4 ± 0.57/10
Alveoli Alveolar macrophages without
pigmentation
0.2 ± 0.12/10 1.0 ± 0.010/10⁄⁄⁄ 1.3 ± 0.29/9⁄⁄⁄ 1.3 ± 0.210/10⁄⁄⁄ 1.3 ± 0.210/10⁄⁄⁄ 1.1 ± 0.110/10⁄⁄⁄ 1.1 ± 0.110/10⁄⁄⁄
Alveolar macrophages with pigmentation 0.1 ± 0.11/10 1.0 ± 0.010/10⁄⁄⁄ 1.0 ± 0.09/9⁄⁄⁄ 1.0 ± 0.010/10⁄⁄⁄ 1.0 ± 0.010/10⁄⁄⁄ 1.0 ± 0.010/10⁄⁄⁄ 1.0 ± 0.010/10⁄⁄⁄
Pigmented macrophage nests 0.5 ± 0.51/10 0.9 ± 0.45/10 2.3 ± 0.68/9⁄⁄ 3.7 ± 0.78/10⁄⁄ 1.1 ± 0.55/10 1.3 ± 0.47/10⁄ 0.5 ± 0.24/10
Remarks: only histopathological endpoints responsive (relative to sham) to either of the smoke-exposures are reported; ⁄, ⁄⁄, and ⁄⁄⁄ indicate statistically differences from sham at p 6 0.05, p 6 0.01, and p 6 0.001, respectively;
LMR, lower medial region; UMR, upper medial region.
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Table 9
Histopathological ﬁndings in the respiratory tract of female rats after the 90-day inhalation period to MS from IND-C, US-C, IND, IND-SC, IND-SC-O, and IND-SC-E cigarettes, or to
air (sham), pairwise statistical comparison.
Localization Tissue type Observation Pairwise statistical comparison (effect of treatment)⁄
(1) Effect
oftobacco
blend
(2) Effect
of
cut cloves
(3) Effect
ofspent
cloves
(4) Effect of
add-back
of oleoresin
(5) Effect of
add-back
of eugenol
Nose Level 1 Respiratory epithelium Loss of goblet cells IND"⁄
Nose Level 2 Olfactory epithelium Atrophy IND-C;⁄⁄
Squamous epithelial metaplasia IND-C;⁄⁄ IND-SC"⁄
Olfactory region Loss of nerve bundles IND-C;⁄⁄
Nose Level 3 Olfactory epithelium Atrophy IND-C;⁄
IND;⁄
Squamous epithelial metaplasia
without corniﬁcation
IND-C;⁄⁄
IND;⁄
Olfactory region Loss of nerve bundles IND-C;⁄
IND;⁄
Nose Level 4 Olfactory epithelium Atrophy IND-C;⁄⁄
IND;⁄⁄
IND-SC"⁄⁄
Squamous epithelial metaplasia
without corniﬁcation
IND-C;⁄⁄
IND;⁄⁄
IND-SC"⁄ IND-SC"⁄⁄
Olfactory region Loss of nerve bundles IND-C;⁄⁄
IND;⁄⁄
IND-SC"⁄⁄
Larynx Ventral depression Squamous epithelial metaplasia
without corniﬁcation
IND"⁄⁄
Squamous epithelial metaplasia with
corniﬁcation
IND"⁄⁄
Vocal cords Squamous epithelial metaplasia with
corniﬁcation
IND"⁄
Pseudo-stratiﬁed
epithelium
Squamous epithelial metaplasia IND-SC;⁄
Vocal folds Squamous metaplasia without
corniﬁcation
IND-C"⁄
Left lung Respiratory epithelium Goblet cell hyperplasia IND;⁄⁄
Alveoli Nests of pigmented macrophages IND"⁄⁄ IND"⁄
Remarks: only histopathological endpoints statistically signiﬁcantly different between cigarette groups are included; signiﬁcant changes are represented by " (increase) and ;
(decrease) at ⁄, p 6 0.05; ⁄⁄, p 6 0.01; ⁄⁄⁄, p 6 0.001.
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constituents in the exposure chamber demonstrated, signiﬁcant
levels of eugenol remained in cigarettes made with spent cloves
(eugenol concentration in exposure chamber 25% of that found
for the cigarettes with cut cloves). Thus it can be speculated that
the observation of reduced lung inﬂammation is most probably
due to the residual amount of eugenol being sufﬁcient to reduce
lung inﬂammation.
Exposure to MS from cigarettes with spent cloves was also asso-
ciated with histopathological changes in the upper respiratory
tract (nose level 2–4) being more severe relative to cigarettes with
cloves (IND-C) and occasionally also exceeding the effects seen
with tobacco-only cigarettes (IND). This was in contrast to the ﬁnd-
ings in the larynx and lung where the effects of cigarettes with
spent cloves were lower than those of IND cigarettes and equal
to those of IND-C cigarettes. These observations cannot be directly
explained by the available data but may be related to combustion
of the clove matrix, reduced amount of tobacco, and higher levels
of smoke constituents with activity in the upper respiratory tract.
Analysis of the exposure atmosphere supports this as the cigarettes
with spent cloves had higher yields of smoke constituents (i.e.,
acrolein, formaldehyde, and acetaldehyde on a per mg TPM basis)
that are known upper respiratory irritants. Actually, it has been
shown that irritative volatile constituents in the gas phase are
mostly responsible for hyperplastic and metaplastic changes in
the nose and the particulate phase of cigarette MS is mostly
responsible for inﬂammation in the lung and hyperplastic and
metaplastic epithelial changes in the larynx (Friedrichs et al.,
2006). Furthermore, it seems that the particulate phase of IND-SC
was less irritative than that of IND.It can be summarized, that the histopathological changes in the
larynx and lungs and the pulmonary inﬂammatory parameters
were lower after addition of spent cloves to the cigarettes.
However, the histopathological effects in the upper respiratory
tract were generally much higher for cigarettes with spent cloves,
compared to those without cloves or with cut cloves.
Set 4: Effect of add-back of oleoresin
When the essential oils from clove were added back to ciga-
rettes with spent cloves (IND-SC-O), the severity of histopatholo-
gical changes in the upper respiratory tract were generally
similar to cigarettes with cut cloves. Only at nose level 4 there
was a reduction in the metaplastic and atrophic lesions. Lung
inﬂammation was also of similar severity when compared to that
of the IND-C and IND-SC cigarettes. Again, it seems that the resid-
ual amount of eugenol and other oleoresins in spent cloves being
sufﬁcient to reduce lung inﬂammation and the added oleoresins
add little to this effect.
Set 5: Effect of add-back of eugenol
Add-back of pure eugenol, the main component of clove essen-
tial oils, to cigarettes with spent cloves was associated with a slight
further reduction in lung inﬂammation relative to cigarettes with
cut cloves. Eugenol did also signiﬁcantly reduce the severity of his-
topathological ﬁndings at nose level 2–4 relative to cigarettes with
spent cloves only. At the deeper part of the nose (nose level 3–4),
most histopathological changes were not observed for any of the
groups where eugenol had been added back to the spent cloves.
At the larynx, no consistent inﬂuence of eugenol on histopatholo-
gical parameters was found. Overall, these ﬁndings demonstrate
a role of the essential oils extracted from clove, and in particular
the eugenol component.
S64 E. Roemer et al. / Regulatory Toxicology and Pharmacology 70 (2014) S54–S654.1. General
The effects associated with eugenol exposure observed in the
90-day inhalation study are consistent with the observations in
the 35-day inhalation study where the impact of eugenol on the
toxicity of an American-blended cigarette was assessed. The
severity of most histopathological changes in the nose and lung
was reduced in the presence of eugenol in a dose-dependent
manner in most cases. In particular, animals exposed to MS
from eugenol-containing cigarettes (all concentrations) were not
statistically signiﬁcantly different from sham exposed rats with
regard to most histopathological ﬁndings at nose level 3 to 4.
Adding eugenol to cigarettes also signiﬁcantly reduced the lung
inﬂammatory potential relative to cigarettes without eugenol.
However, lung inﬂammation was still signiﬁcantly elevated rela-
tive to background level seen in sham exposed rats. The eugenol
content in the inhalation chamber was similar for the US-2.5 and
Garam (72.7 vs. 70.5 lg/l, respectively) cigarettes, the inﬂamma-
tory potential of Garam was however signiﬁcantly less than
US-2.5. Accordingly, the eugenol content does not appear to fully
explain the reduced inﬂammatory potential found with kretek
cigarettes. Overall, these ﬁndings closely resemble what was
observed in the 90-day inhalation study of Garam relative to
2R4F (Piadé et al., 2014b) and conﬁrm an important role of
eugenol.
Pure eugenol has been demonstrated to have anti-inﬂammatory
effects (Fujisawa et al., 2000; Magalhaes et al., 2010; Pramod et al.,
2010; Slamenova et al., 2009). As eugenol primarily is found in the
particulate fraction of kretek smoke (Polzin et al., 2007), and which
is respirable and reaches the lung, it is therefore likely to contrib-
ute to the reduced neutrophil count observed in the studies
reported here. A panel of molecular markers of inﬂammation was
also included in the 90-day study and supports this ﬁnding. In
particular, MIP1a and MCP1 responded to cigarette smoke and
differences in levels could be observed between cigarettes
containing clove oil or eugenol and tobacco-only cigarettes. Both
are chemokines involved in early inﬂammatory response by
activation and recruitment of neutrophils and other leukocytes
(Carr et al., 1994; Cook, 1996; Wolpe et al., 1988) and were seen
dose-dependently increased in rat lungs following a 28-day
exposure to smoke from the standard reference cigarette 3R4F
(Kogel et al., 2014). The effect of eugenol on smoke chemistry
should nevertheless also be considered when evaluating these
results. The presence of eugenol in cigarettes dilutes the smoke
constituents in MS; on a per mg TPM basis there was a decrease
of most smoke constituents. Accordingly, the general decrease in
smoke constituents most likely also contributed to the reduction
of lung inﬂammation. Additional changes in the generation of
smoke constituents are also observed (Roemer et al., 2014b) but
the impact of this is unclear. However, it can be assumed that
the reduced yield of smoke constituents on a per mg TPM basis
may also partially explain the reduced severity of histopathological
ﬁndings.
Local anesthetic and analgesic effects of eugenol in the respira-
tory tract could change animal response, e.g., breathing pattern
and presumably lead to higher inhalation exposure. However,
results from the respiratory physiology evaluation as well as the
amount of excreted nicotine metabolites included in these studies
revealed only minor and most likely incidental differences that
could not be correlated with the histopathology results.
5. Conclusion
These studies conﬁrm the ﬁndings from the comparative
assessment of American-blended reference cigarette 2R4F with
the marketed kretek cigarette Garam and the Kretek-R cigarette.An experimental cigarette with an Indonesian blend of tobacco
and cloves representative of kretek cigarettes (i.e., similar to
Kretek-R) is less active in rats regarding irritative changes in the
upper respiratory tract and inﬂammatory responses in the lung
than a typical American-blended cigarette following a 90-day inha-
lation of MS from these cigarettes. The lower activity is not related
to the type of tobacco blend, but reﬂects the presence of cloves.
There are indications that the combustion products of the clove
matrix (with a distinct reduction of the essential oils and/or
eugenol) may be more irritant than the combustion products of
tobacco. The lower toxicological activity of cigarettes with
un-extracted cloves compared to those without cloves is most
likely due to a combination of the pharmacological properties of
eugenol, a dilution of smoke constituents by eugenol, and a change
in the combustion process leading to a reduction of some irritative
smoke constituents.
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